These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2982221)

  • 1. [Radiation dose to the lung following endolymphatic radionuclide therapy of melanoma of the lower limbs].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Jan; 161(1):23-9. PubMed ID: 2982221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphographically detectable long-term changes caused by endolymphatic radionuclide therapy (ELRT) in the infradiaphragmatic lymph system].
    Müller RP; Peters PE
    Strahlentherapie; 1985 Apr; 161(4):239-43. PubMed ID: 2986321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiation-dosimetry studies after endolymphatic radionuclide therapy].
    Pfannenstiel P
    Med Welt; 1974 Jun; 25(23):1038-42. PubMed ID: 4369658
    [No Abstract]   [Full Text] [Related]  

  • 4. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 5. Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.
    Weissleder H; Pfannenstiel P; Peters PE
    Lymphology; 1976 Sep; 9(3):122-6. PubMed ID: 187879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma].
    Edwards JM
    Minerva Med; 1967 Dec; 58(99):4512-3. PubMed ID: 4295505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reliability of the diagnostic results obtained with confined quantities of the contrast medium in endolymphatic radionuclide therapy (ELRT) of the inferior limbs (author's transl)].
    Müller RP; Schnepper E; Peters PE; Fladerer W
    Strahlentherapie; 1980 Aug; 156(8):538-41. PubMed ID: 7414647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
    Makoski HB; Scherer E; Magnus L; Verbeek W
    Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary oil deposition in patients subjected to lymphography: Detection by thoracic photoscan and sputum examination.
    Richardson P; Crosby EH; Bean HA; Dexter D
    Can Med Assoc J; 1966 May; 94(21):1086-91. PubMed ID: 4286715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Follow-up studies on malignant melanomas after endolymphatic radionuclide therapy].
    Gehring D; Baumeister L
    Med Welt; 1974 Jun; 25(23):1045-7. PubMed ID: 4409591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern contrast preparations for lymphography and their prospective performance].
    Sviridov NK
    Med Radiol (Mosk); 1985 Sep; 30(9):68-71. PubMed ID: 2995758
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary radiation exposure following endolymphatic therapy. 3. Dosimetric distribution study in rabbit lung following endolymphatic therapy].
    Stauch GW; Makoski HB; Magnus L; Heissen E
    Strahlentherapie; 1973 Jun; 145(6):644-51. PubMed ID: 4375317
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary miliary shadows due to lipiodol following lymphography].
    Bujar H; Roxin T
    Ann Radiol (Paris); 1971; 14(7):601-8. PubMed ID: 4330418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Indication establishment and dosimetry in endolymphatic therapy with I-131 lipiodol].
    Winkel K; Becker J; Jahns E; Scheurlen H; Herzfeld U
    Strahlentherapie; 1967 Aug; 133(4):481-98. PubMed ID: 4298455
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary oil emboli after lymphography.
    Hallgrimsson J; Clouse ME
    Arch Pathol; 1965 Oct; 80(4):426-30. PubMed ID: 4284343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tabular and case demonstrations of 100 malignant melanomas treated by endolymphatic therapy].
    Makoski HB; Scherer E
    Med Welt; 1974 Jun; 25(23):1042-4. PubMed ID: 4605981
    [No Abstract]   [Full Text] [Related]  

  • 17. Body distribution of intralymphatically injected radioactive colloid and oil.
    Erjavec M; Hacek S; Havlicek M; Klanjscek G
    Radiobiol Radiother (Berl); 1969; 10(4):571-8. PubMed ID: 4312058
    [No Abstract]   [Full Text] [Related]  

  • 18. The intralymphatic administration of radioactive isotopes in the overall treatment of malignant melanoma.
    Ariel IM; Resnick MI; Oropeza R
    J Nucl Med; 1967 May; 8(5):347-8. PubMed ID: 4292414
    [No Abstract]   [Full Text] [Related]  

  • 19. [Administration by the lymphatic route of radioactive isotopes for therapeutic purposes].
    Ratti A
    Minerva Med; 1966 Dec; 57(102):4440-5. PubMed ID: 4289275
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radionuclide treatment of lymph node metastases in malignant melanoma].
    Weissleder H; Pfannenstiel P
    Hautarzt; 1973 Jan; 24(1):21-4. PubMed ID: 4348909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.